Previous Article | Next Article ![]()
Infection and Immunity, October 2006, p. 5725-5729, Vol. 74, No. 10
0019-9567/06/$08.00+0 doi:10.1128/IAI.00682-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Rolf Fendel,1,2
Benjamin Mordmueller,1,2
Ayola A. Adegnika,1,2,3
Peter G. Kremsner,1,2 and
Adrian J. F. Luty1,2*
Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon,1 Institute for Tropical Medicine, Department of Parasitology, University of Tübingen, Tübingen, Germany,2 Department of Parasitology, Leiden University Medical Centre, Leiden, The Netherlands3
Received 28 April 2006/ Returned for modification 31 May 2006/ Accepted 7 July 2006
|
|
|---|
|
|
|---|
While the malaria-associated alterations of DC functions outlined above have been put forward as possible causes of reduced vaccine efficacy in regions where P. falciparum is endemic, and while small children are considered to constitute a high-risk group not least because of adverse immunological effects of prenatal exposure to P. falciparum, there are few published data on P. falciparum infection-related immunology in the neonatal compartment. DC function during fetal and neonatal development is generally not well defined, and although it is known that placental P. falciparum infection leads to sensitized fetal T cells (2-4, 8, 11, 17), the role of fetal DC in this context is unknown. Here, therefore, we investigated the effects of pregnancy-associated P. falciparum infection on fetal DC, using flow cytometry (fluorescence-activated cell sorting) to enumerate mDC and pDC in cord blood (CB) of offspring of women delivering in Lambaréné, Gabon. In parallel we assessed DC surface HLA-DR expression as a surrogate marker for DC capacity to present antigens to other immune cells. Data were analyzed as a function of maternal P. falciparum infection status.
|
|
|---|
Laboratory methods. Cord blood and maternal peripheral venous blood were collected into sterile heparin-containing tubes at or immediately after delivery, and specimens were obtained for placental thick smears. Cord blood mononuclear cells (CBMC) were isolated from diluted CB by a standard procedure with Ficoll (Apotheek AZL, The Netherlands), washed, and resuspended at 107 cells/ml in culture medium (Iscoves modified Dulbeccos medium; GIBCO) supplemented with 10% fetal calf serum (GIBCO), 1 mM pyruvate, 2 mM glutamate, 100 U/ml penicillin, and 100 µg/ml streptomycin. One-milliliter aliquots of this suspension were centrifuged and washed twice in 1 ml of phosphate-buffered saline containing 2 mM EDTA and 0.5% bovine serum albumin (SIGMA-Aldrich, Germany), and 10 µl of FcR blocking reagent (Miltenyi Biotec, Germany) was added to aliquots of 106 cells prior to incubation with specific antibodies.
Fluorescence-labeled BDCA-1-/BDCA-2-specific antibodies (Miltenyi) were used to identify mDC and pDC. DC surface HLA-DR was revealed by HLA-DR-specific antibody (Becton Dickinson). Anti-CD34 and a lineage marker antibody cocktail (CD3, CD14, CD16, CD19, CD20, and CD56) were used to exclude non-DC populations, and controls comprised appropriately labeled mouse monoclonal antibody isotypes (all from Becton Dickinson). CBMC-antibody incubations were for 30 min at room temperature in the dark. Data from fluorescing DC were acquired with a flow cytometer (Partec, Germany), analyzing 300,000 events for DC and 200,000 events for isotype control enumerations. mDC/pDC were identified as BDCA-1+/BDCA-2+ lineage marker-negative (lin) cells appearing in the forward-/side-scatter region of lymphocytes/monocytes (Fig. 1A). This identification of DC subsets follows their published characterization (7): in size and granularity, DC appear somewhat similar to lymphocytes and monocytes, and restricting the marker analysis to cells showing the corresponding forward-/side-scatter profile may reduce unspecific noise; in terms of surface antigens, mDC and pDC express with good specificity BDCA-1 (CD1c) and BDCA-2 (CD303), respectively, but lack common markers of various immune cell lineages. Using the lineage cocktail to identify and exclude cells expressing the respective DC marker but also any lineage-associated antigens further increases the specificity of our enumeration.
![]() View larger version (38K): [in a new window] |
FIG. 1. Flow cytometry for and distribution of CBDC subsets. (A) Flow cytometric identification of mDC (lin BDCA-1+) and pDC (lin BDCA-2+) in one subject's cord blood mononuclear cells from the lymphocyte/monocyte scatter region is shown in the upper left and right dot plots, respectively. Below, the isotype control for quantification of unspecific binding (mDC staining) and the gating of HLA-DR+ mDC are presented for the same sample. For details, see the text. (B) Concentrations of mDC and pDC were analyzed as a function of Plasmodium falciparum exposure in utero. The box-and-whisker plots illustrate medians and percentiles with outliers (open circles) and demonstrate higher mDC frequencies in CB of exposed offspring; dot plots show the negative associations between CB mDC/pDC numbers and maternal age, in the case of mDC including intercept shifts due to past or present exposure as revealed by two-way ANOVA. NE, nonexposed; T, treated; I, infected.
|
CB samples were grouped according to maternal P. falciparum infection history (nonexposed, treated, or infected) determined by routine microscopic examination of Giemsa-stained thick smears at delivery, inspection of the mothers' health data, and thorough anamnesis.
Data analysis. DC parameters were compared between groups by analysis of variance (ANOVA), applying log transformation where appropriate, with the significance of differences determined by Dunnett's test, using the statistical software "R" version 2.0.1 (R Foundation for Statistical Computing, Vienna, Austria) and its extension "multcomp" (F. Bretz et al., http://cran.r-project.org/bin/windows/contrib/r-release/multcomp_0.4-8.zip) for multiple-comparison procedures.
|
|
|---|
12,400/ml (95% confidence interval [CI], 8,800 to 17,600/ml). Consistent with the findings of others (26), our CB samples contained no CD34+ lin DC marker-positive cells. Consequently, the stem cell marker was omitted after preliminary experiments. Total and HLA-DR+ mDC numbers differed between groups (P = 0.021 and P = 0.019, respectively, by one-way ANOVA) and were found to be significantly higher in CB of the infected group compared to the nonexposed group (P = 0.028 and P = 0.027, respectively, by Dunnett's test), with similar but nonsignificant trends for more mDC/HLA-DR+ mDC in CB of the treated group (P = 0.061 and P = 0.053, respectively) (Fig. 1B; Table 1). When controlling for maternal age, which was the only confounding variable that was significantly associated with mDC numbers in one-way ANOVA, the association with malarial status was strengthened (P = 0.014 [total mDC] and P = 0.013 [HLA-DR+ mDC] by two-way ANOVA). Numbers of pDC showed similar trends, but these measurements were associated with higher dispersion than for mDC and remained statistically insignificant (Fig. 1B; Table 1). Our findings highlight clear differences between fetal DC exposed to P. falciparum in utero and DC in children with acute P. falciparum malaria, in whom DC (lin CD83+) numbers are normal but numbers of lin HLA-DR+ cells are decreased compared to those in healthy controls (29). In adults with acute P. falciparum malaria, pDC concentrations are decreased, while plasma alpha interferon levels are increased (21). Since pDC are major producers of alpha interferon, especially upon activation, these findings were interpreted as reflecting activation-induced migration of pDC into lymphoid sites. The observation of elevated mDC concentrations associated with in utero exposure to P. falciparum, together with identical trends for pDC, imply that placental P. falciparum infection indeed leads to activation of fetal DC, but clearly without any associated decrease in CBDC numbers. This may reflect the altered regulation of chemokine receptors in CBDC compared to adult DC (13). Such putatively impaired coordination of postactivation migratory processes in CBDC exposed to P. falciparum in utero merits further study. In any case, the offspring of mothers with placental P. falciparum infection at delivery have been shown to have earlier and more frequent parasitemia in the first year of life (5, 14, 19). Whether a causal link exists between this enhanced postnatal susceptibility to infection and the prenatal expansion of DC populations that we document here remains an open question.
|
View this table: [in a new window] |
TABLE 1. Blood counts and dendritic cell measures in cord blood samples segregated according to maternal malaria historya
|
CB contained pDC at a significantly higher concentration than mDC (P < 0.001 by paired t test after log transformation), resulting in a mean mDC/pDC ratio of 0.69 (95% CI, 0.58 to 0.82). There is no current consensus regarding the normal physiological CB mDC/pDC ratio. Intriguingly, both published studies that used the same CBDC markers as we did reported finding about fourfold more mDC (6, 22). These differences most likely reflect the different study populations: our study is the first to describe CBDC subset distributions in an African population.
Independently of exposure to P. falciparum in utero, the numbers of both mDC and pDC in CB declined with increasing maternal age, with coefficients of 0.065 (95% CI, 0.124 to 0.007; P = 0.029 [two-way ANOVA]) and 0.082 (95% CI, 0.157 to 0.007; P = 0.033 [one-way ANOVA]) for log-transformed mDC and pDC concentrations, respectively (Fig. 1B). We currently have no explanation for this intriguing observation. In the present study, our flow cytometric examinations were limited to neonatal samples due to resource constraints. Analyses of matched maternal samples would not only shed some light on the maternal age-CBDC relationship described but would also enable us to correlate the P. falciparum-associated neonatal changes with maternal equivalents.
In a majority of CB samples from those exposed to P. falciparum in utero, parasite antigen-specific T-cell responses show an interleukin-10 (IL-10) or Th2-like bias that contrasts with the Th1-like bias in P. falciparum-infected placentas (9, 11, 17). Despite their high functional plasticity, mDC are generally thought to induce Th1-type responses, but CB mDC have an impaired capacity for IL-12 production (10). Furthermore, partially activated DC lead to the expansion of regulatory T cells (24). Our own work has revealed inducible IL-10-producing Tr1-type regulatory T cells in CB of newborns with in utero P. falciparum exposure, associated with a Th2-type bias of parasite-specific T-cell responses (2-4). Taken together, our results are consistent with the hypothesis that sustained exposure to transplacentally transferred P. falciparum components stimulates immature fetal DC that induce an immunosuppressive/Th2-type immune milieu. The role of either mDC or pDC in this context is open to speculation, but we have shown that HLA expression by CB monocytes of the infected group is suppressed by parasite antigens in vitro (4), suggesting possible functional impairment of antigen-presenting cells in vivo. Neonates are the target population for malaria vaccines that are being developed, and it is of obvious concern that the efficacy of such vaccines in early life might potentially be compromised by inappropriately suppressed parasite-specific T-cell responses, the etiology of which may be related to the P. falciparum-related CBDC alterations that we describe here.
.
We are grateful for the patient cooperation of all our study participants and acknowledge the kind support received from midwives, administrations, and staffs of the two hospitals and the Medical Research Unit. Fruitful discussions with Ilka Engelmann and Sanders Chai contributed to this work, and we thank Selidji Agnandji, Martin Kramer, and Daniela Schütte for their helping hands. The Leeds University Skin Research Centre assisted in the preparation of the fluorescence-activated cell sorter plots.
L.P.B. designed and performed research, analyzed data, and wrote the paper; R.F. and B.M. assisted with research methodology and analysis; A.A.A. performed research; P.G.K. designed and supervised research; and A.J.F.L. designed and supervised research and wrote the paper.
Present address: Research Institute of Integrative and Comparative Biology, University of Leeds, Leeds, United Kingdom. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»